| Title |
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
|
|---|---|
| Published in |
Cancer Discovery, October 2020
|
| DOI | 10.1158/2159-8290.cd-20-0941 |
| Pubmed ID | |
| Authors |
Donna R. Rivera, Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih-Yuan Hsu, Samuel M. Rubinstein, Brendan J. Lee, Toni K. Choueiri, Gilberto de Lima Lopes, Petros Grivas, Corrie A. Painter, Brian I. Rini, Michael A. Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B. Doroshow, Pamela C. Egan, Dimitrios Farmakiotis, Leslie A. Fecher, Christopher R. Friese, Matthew D. Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R. Halfdanarson, Balazs Halmos, Jessica E. Hawley, Ali Raza Khaki, Christopher A. Lemmon, Sanjay Mishra, Adam J. Olszewski, Nathan A. Pennell, Matthew M. Puc, Sanjay G. Revankar, Lidia Schapira, Andrew Schmidt, Gary K. Schwartz, Sumit A. Shah, Julie T. Wu, Zhuoer Xie, Albert C. Yeh, Huili Zhu, Yu Shyr, Gary H. Lyman, Jeremy L. Warner |
X Demographics
The data shown below were collected from the profiles of 196 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 99 | 51% |
| United Kingdom | 6 | 3% |
| France | 5 | 3% |
| Mexico | 4 | 2% |
| Spain | 4 | 2% |
| India | 4 | 2% |
| Italy | 3 | 2% |
| Canada | 2 | 1% |
| Australia | 2 | 1% |
| Other | 19 | 10% |
| Unknown | 48 | 24% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 104 | 53% |
| Scientists | 56 | 29% |
| Practitioners (doctors, other healthcare professionals) | 23 | 12% |
| Science communicators (journalists, bloggers, editors) | 13 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 297 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 297 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 32 | 11% |
| Student > Bachelor | 28 | 9% |
| Student > Master | 27 | 9% |
| Student > Ph. D. Student | 24 | 8% |
| Other | 21 | 7% |
| Other | 53 | 18% |
| Unknown | 112 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 75 | 25% |
| Nursing and Health Professions | 21 | 7% |
| Biochemistry, Genetics and Molecular Biology | 8 | 3% |
| Psychology | 7 | 2% |
| Unspecified | 7 | 2% |
| Other | 45 | 15% |
| Unknown | 134 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 299. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2023.
All research outputs
#118,007
of 25,998,826 outputs
Outputs from Cancer Discovery
#41
of 4,153 outputs
Outputs of similar age
#3,615
of 436,176 outputs
Outputs of similar age from Cancer Discovery
#2
of 83 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,153 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,176 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.